Summary
Cognizant Technology Solutions Corporation (CTSH) reported strong revenue growth of 20.2% year-over-year to $2.91 billion for the first quarter ended March 31, 2015. This growth was significantly driven by the acquisition of TriZetto in late 2014, which contributed to a 42.7% surge in the Healthcare segment. Net income also saw a healthy increase of 9.7% to $382.9 million, with diluted EPS rising to $0.62. Despite robust top-line performance, operating margin slightly decreased to 17.2% from 19.0% in the prior year. This was attributed to increased compensation and benefits costs due to headcount growth, higher subcontractor expenses, and investments in business expansion, partially offset by reduced losses on cash flow hedges. The company maintains a strong liquidity position with $3.35 billion in cash, cash equivalents, and short-term investments.
Financial Highlights
48 data points| Revenue | $2.91B |
| SG&A Expenses | $611.00M |
| Operating Income | $500.00M |
| Interest Expense | $5.00M |
| Net Income | $383.00M |
| EPS (Basic) | $0.63 |
| EPS (Diluted) | $0.62 |
| Shares Outstanding (Basic) | 609.60M |
| Shares Outstanding (Diluted) | 613.90M |
Key Highlights
- 1Revenue increased by 20.2% to $2.91 billion, driven by strong performance across segments and the TriZetto acquisition.
- 2Healthcare segment revenue grew by a significant 42.7%, largely due to the TriZetto acquisition.
- 3Net income rose by 9.7% to $382.9 million, with diluted EPS increasing to $0.62.
- 4Operating margin declined to 17.2% from 19.0% due to increased operating expenses related to headcount growth and business investments.
- 5The company generated $189.3 million in cash from operating activities, an increase from the prior year.
- 6Cognizant held $3.35 billion in cash, cash equivalents, and short-term investments as of March 31, 2015, indicating strong liquidity.
- 7The company repurchased $25.0 million of its Class A common stock under its repurchase program during the quarter.